Stock options in privately held companies
Visit a quote page and your recently viewed tickers will be displayed here.
Shares of Cytori Therapeutics Inc. Earlier Tuesday, the company said it priced an public offering of 8. Cytori Therapeutics' CYTX CEO Marc Hedrick on Q1 Results - Earnings Call Transcript. Cytori Therapeutics Inc NASDAQ: The FDA cleared Cytori to launch a pilot clinical study for its burn therapy.
Cytori Therapeutics' CYTX CEO Marc Hedrick on Q4 Results - Earnings Call Transcript. Today's Research Report Coverage on Biotech Stocks -- Cyclacel Pharma, Cytori Therapeutics, La Jolla Pharma, and Moleculin Biotech. Cytori R Partners with myTomorrows for Managed Access Program for Europe, Middle East and Latin America. Cytori Provides Latest Corporate Update at the 18th Annual B. One Year Follow Up of Cytori Cell Therapy TM in Investigator Erectile Dysfunction Trial.
Today's Research Reports on Biotech Stocks to Watch: Cytori Therapeutics and Geron. FDA Approval for Burn Clinical Trial Related to BARDA Contract. Data from preclinical studies and clinical trials suggest that Cytori Cell Therapy acts principally by improving blood flow, modulating the immune system and facilitating wound repair.
The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July and is headquartered in San Diego, CA. By using this site you agree to the Terms of ServicePrivacy Policyand Cookie Policy.
Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information.
All quotes are in local exchange time. Real-time last sale data for U. Intraday data delayed at least 15 minutes or per exchange requirements. Storyful, a division of News Corp, which owns MarketWatch, is a leading social media services company headquartered in Dublin, Ireland. Storyful combines world class journalism with industry-leading technology to discover, verify and acquire original content and provide the on-the-ground sources news and media organizations need to tell the stories that matter to their audience.
US Europe Asia FX Rates Futures Range 1D 5D 1M 3M 6M 1Y 2Y FTSE 7, Latest News All Times Eastern. President takes Georgia victory lap, talks terrorism with Saudi prince 4: Penney shares close Wednesday down 5. This chart puts it all in perspective. Home Investing Quotes Stocks United States CYTX Overview Compare Quotes Stock Screener Earnings Calendar Sectors Nasdaq.
Watch list Create CYTX Alert. Jun 21, 3: Advanced Charting 1D 5D 1M 3M 6M YTD 1Y 3Y All. Customize MarketWatch Have Watchlists? Log in to see them here or sign up to get started. Create Account … or Log In. No Items in Watchlist There are currently no items in this Watchlist. Add Ticker to Watchlist. Go to Your Watchlist. No Saved Watchlists Create a list of the investments you want to track. Create Watchlist …or try this starter list.
Uh oh Something went wrong while loading Watchlist. No Recent Tickers Visit a quote page and your recently viewed tickers will be displayed here.
Overview Profile News Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders. Performance 5 Day Recent News MarketWatch Other Dow Jones Stocks end slightly lower as geopolitical, policy uncertainties weigh Apr. ET by Victor Reklaitis.
Cytori Therapeutics' stock plunges toward record low after stock offering prices at deep discount Shares of Cytori Therapeutics Inc. ET by Tomi Kilgore. Cytori Therapeutics' stock on track to open at all-time low Cytori How did 9/11 affect the stock market stock on track to open at all-time low Apr. Cytori Therapeutics stock surges 7.
ET by Emma Court. Three health-care deals today are paying huge premiums Mar. ET by Philip van Doorn. ET by Steve Gelsi. ET by David B. ET by Val Brickates Can you earn kohls cash with kohls cash. ET by Greg Morcroft. Osiris stem-cell therapy wins Canadian approval May. Cytori shares climb on FDA approval Mar. Court upholds stem-cell research funding: Are stem-cell stocks a good buy?
Amylin and Alkermes shine in drug-stocks trading Jul. Stem-cell stocks rise on artificial-trachea report Jul. Impax leads drug stocks lower Jun. Four Biotech Picks for Cures Law Jan. Biotechs and the 21st Century Stock options in privately held companies Act Dec. New FDA Guidance Target Cellular Therapy Nov. Walgreen, Time Warner, Sprint Aug. ET on The Wall Street Journal. Cytori Halts Athena Trials Over Safety Concerns Aug.
Endo Health, Michael Kors, CVS Nov. KPMG Will Reassess Safeguards in Wake of Trading Case Apr. Adobe Systems, VeriFone, Alexza Pharma Dec. Research In Motion, Walgreen, Nike Sep. Cogo, Perfect World, Anthera and More Mar. LDK Solar, Hovnanian, Layne Christensen and More Jun. Websense, Carbo Help Small Stocks Slough Off Jobs Data Jan. Small-Cap Stocks Rise Nov. Geron to Provide Stem Cells to GE Jun. Federal Order Boosts Stem Cell Names Mar.
How to Choose an Employee Stock Plan for Your Company
Metastock trading range Short Rules Drive Up Some Stock Prices Binary options trading forbes. ET on Barron's Online.
Stem Cells and Breast Surgery Aug. Fat Could Restore Breasts After Cancer Surgery Jan. ET on Seeking Alpha. Cytori Therapeutics' CYTX CEO Marc Hedrick on Q1 Results - Earnings Call Transcript Cytori Therapeutics' CYTX CEO Marc Hedrick on Q1 Results - Earnings Call Transcript May. Cytori Therapeutics Inc CYTX Tumbles to Week Low on Back of Share Dilution Cytori Therapeutics Inc NASDAQ: Cytori Get FDA Approval for Clinical Burn Trial The FDA cleared Cytori to launch a pilot clinical study for its burn therapy.
Stock options in privately held companies Nordic stock exchange wiki as of 9: Cytori Therapeutics' CYTX CEO Marc Hedrick on Q4 Results - Earnings Call Transcript Cytori Therapeutics' CYTX CEO Marc Hedrick on Q4 Results - Earnings Call Transcript Mar.
Week 7 Breakout Forecast And 5 Week Summary: Short-Term Picks To Give You An Edge Feb. Cytori Therapeutics CYTX Presents at 9th Annual Conference Biotech Showcase Jan.
Stock Option Pricing and Valuation by Private Companies - A
Cytori enters stock purchase agreement with Lincoln Park Capital Dec. President Obama Signs 21st Century Cures Act - Implications For The Stem Cell Sector Dec. Cytori Scleroderma Study Two-Year Follow-Up Data Published Nov.
Cytori Therapeutics' CYTX CEO Marc Hedrick on Q3 Results - Earnings Call Transcript Nov. Today's Research Report Coverage on Biotech Stocks -- Cyclacel Pharma, Cytori Therapeutics, La Jolla Pharma, and Moleculin Biotech Today's Research Report Coverage on Biotech Stocks -- Cyclacel Pharma, Cytori Therapeutics, La Jolla Pharma, and Moleculin Biotech Jun.
ET on PR Newswire - PRF. Cytori R Partners with myTomorrows for Managed Access Program for Europe, Middle East and Latin America Cytori R Partners with myTomorrows for Managed Access Program for Europe, Middle East and Latin America Jun. Cytori to Introduce Next-Generation Celution R Technology Cytori to Introduce Next-Generation Celution R Technology Jun. Cytori Logs Final 48 Week Patient Follow Up Visit in Scleroderma Trial Cytori Logs Final 48 Week Patient Follow Up Visit in Scleroderma Trial May.
Institutional Investor Conference Cytori Provides Latest Corporate Update at the 18th Annual B. Institutional Investor Conference May. Cytori Reports First Quarter Business and Financial Results Cytori Reports First Quarter Business and Financial Results May. One Year Follow Up of Cytori Cell Therapy TM in Investigator Erectile Dysfunction Trial One Year Follow Up of Cytori Cell Therapy TM in Investigator Erectile Dysfunction Trial May.
Cytori Therapeutics Announces Inducement Grants for New Employees Cytori Therapeutics Announces Inducement Grants for New Employees May. Cytori to Webcast First Quarter Financial Results on May 11 Cytori to Webcast First Quarter Financial Results on May 11 Apr. Cytori Therapeutics and Geron Today's Research Reports on Biotech Stocks to Watch: Cytori Therapeutics and Geron Apr.
Cytori Announces Proposed Public Offering of Common Stock Cytori Announces Proposed Public Offering of Common Stock Apr. FDA Approval for Burn Clinical Trial Related to BARDA Contract Cytori Receives U.
Employee stock options - May. 28,
FDA Approval for Burn Clinical Trial Related to BARDA Contract Apr. Cytori Appoints Gregg Lapointe to Board of Directors Cytori Appoints Gregg Lapointe to Board of Directors Apr. Cytori Reports Fourth Quarter and Full Year Business and Financial Results Mar. Cytori to Webcast Fourth Quarter Financial Results on March 23rd Mar.
Scleroderma Diagnostics and Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast - Mar. Technology and Telemedicine Advancements in Healthcare Boosting Improved Patient Care Feb. Analyst Ratings Sell Under Hold Over Buy Number of Ratings 3 Full Ratings. Ascendiant Capital Initiates Cytori Therapeutics With Buy May.
Benzinga's Top Initiations May. What Maxim Thinks Of Cytori After Its Huge Week Apr.
MarketWatch Site Index Topics Help Feedback Newsroom Roster Media Archive Premium Products Mobile. Dow Jones Network WSJ. Trending Tickers Powered by ORCL 1.